5 completed, 1 withdrawn. 3 Not applicable, 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow alpha-cyclodextrin: new trials by email Literature Review of alpha-cyclodextrin trials Research Report on alpha-cyclodextrin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determining Lipid Content in Stool After Alpha-cyclodextrin Alpha-cyclodextrin, Placebo, Triolein radiolabeled with 100 microcuries of 3^Hydrogen - Healthy Participants | Not applicable | Completed | Mayo Clinic | 8 | 2017-01-20 | 2017-11-17 |
| FBCx (Alpha-CD) Mechanism of Action Trial Alpha-cyclodextrin, Placebo - Healthy Volunteers | Not applicable | Completed | SFI Research | 8 | 2017-01-01 | 2017-08-11 |
| Sulforadex in Healthy Human Males MAD Sulforadex, alpha-cyclodextrin - Prostate Cancer | Phase 1 | Completed | Evgen Pharma | 18 | 2014-01-01 | 2015-02-10 |
| The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion Alpha-cyclodextrin and digestible starch, Alpha-cyclodextrin, Digestible starch - Obesity, Cardiovascular Disease | Not applicable | Withdrawn | Pennington Biomedical Research Center | 2013-10-01 | 2016-04-27 | |
| Sulforadex in Healthy Volunteers SAD Sulforadex, Alpha cyclodextrin - Stage, Prostate Cancer | Phase 1 | Completed | Evgen Pharma | 29 | 2012-11-01 | 2013-09-23 |
| Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum Cholesterol Placebo, Alpha cyclodextrin - Cardiovascular Disease | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 103 | 2010-03-01 | 2016-10-21 |
Cardiovascular Diseases (2) · Prostatic Neoplasms (2) · Atherosclerosis (1) · Heart Diseases (1) · Obesity (1)
Evgen Pharma (2) · Mayo Clinic (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Pennington Biomedical Research Center (1) · SFI Research (1)
United States (3) · United Kingdom (2) · Australia (1)
Frank L Greenway, M.D. (1) · Marcelo J Amar, M.D. (1) · Michael D Jensen, M.D. (1) · Michael D Jensen, MD (1)